Compare PGYWW & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PGYWW | MDCXW |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | 531 | 12 |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | PGYWW | MDCXW |
|---|---|---|
| Price | $0.11 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 58.5K | 1.2K |
| Earning Date | 02-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,032,248,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.12 | N/A |
| 52 Week Low | $0.05 | $0.42 |
| 52 Week High | $0.72 | $3.50 |
| Indicator | PGYWW | MDCXW |
|---|---|---|
| Relative Strength Index (RSI) | 29.82 | 58.44 |
| Support Level | $0.11 | $0.76 |
| Resistance Level | $0.39 | $1.13 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 8.37 | 71.89 |
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.